Ibuprofen augments pro-inflammatory cytokine release in a mouse model of Vibrio vulnificus infection

Microbiology and Immunology

Volumn 54, Issue 9, 2010, Pages 542-550

  Lee, Yuarn Jang ^a   Chuang, Yin Ching ^b  

^a TAIPEI MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b CHI MEI MEDICAL CENTER   (Taiwan)

Author keywords

Cytokine; Ibuprofen; Interleukin 1 ; Non steroidal anti inflammatory drug; Vibrio vulnificus infection

Indexed keywords

IBUPROFEN; INTERLEUKIN 1BETA; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 2; SODIUM CHLORIDE; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE; NONSTEROID ANTIINFLAMMATORY AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD ANALYSIS; COLONY FORMING UNIT; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DISEASE MODEL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; INOCULATION; MORTALITY; MOUSE; NONHUMAN; PERITONEAL FLUID; SEPTIC SHOCK; SURVIVAL RATE; TREATMENT DURATION; VIBRIO VULNIFICUS; VIBRIO VULNIFICUS INFECTION; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; IMMUNOLOGY; VIBRIOSIS;

MUS; VIBRIO VULNIFICUS;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CYTOKINES; DISEASE MODELS, ANIMAL; FEMALE; IBUPROFEN; MICE; MICE, INBRED BALB C; VIBRIO INFECTIONS; VIBRIO VULNIFICUS;

EID: 77957924314     PISSN: 03855600     EISSN: 13480421     Source Type: Journal    
DOI: 10.1111/j.1348-0421.2010.00249.x     Document Type: Article

References (33)

1. Wu H.S., Liu D.P., Hwang C.H., Chen M.J., Hwang J.L., Liu Y., Shankuan L.C., Lin C.S., Wu T.N. (1996) Survey on the distribution of Vibrionaceae at the seaport areas in Taiwan, 1991-1994. Zhonghua Min Guo Wei Sheng Wu Ji Mian YiXue Za Zhi 29: 197-209.
2. Hsueh P.R., Lin C.Y., Tang H.J., Lee H.C., Liu J.W., Liu Y.C., Chuang Y.C. (2004) Vibrio vulnificus in Taiwan. Emerg Infect Dis 10: 1363-8.
3. Chiang S.R., Chuang Y.C. (2003) Vibrio vulnificus infection: clinical manifestations, pathogenesis, and antimicrobial therapy. J Microbiol Immunol Infect 36: 81-8.
4. Chuang Y.C., Yuan C.Y., Liu C.Y., Lan C.K., Huang A.H. (1992) Vibrio vulnificus infection in Taiwan: report of 28 cases and review of clinical manifestations and treatment. Clin Infect Dis 15: 271-6.
5. Klontz K.C., Lieb S., Schreiber M., Janowski H.T., Baldy L.M., Gunn R.A. (1988) Syndromes of Vibrio vulnificus infections. Clinical and epidemiologic features in Florida cases, 1981-1987. Ann Intern Med 109: 318-23.
6. Salgado A., Bóveda J.L., Monasterio J., Segura R.M., Mourelle M., Gómez-Jiménez J., Peracaula R. (1994) Inflammatory mediators and their influence on haemostasis. Haemostasis 24: 132-8.
7. Dinarello CA. (1991) The proinflammatory cytokines interleukin-1 and tumor necrosis factor and treatment of the septic shock syndrome. J Infect Dis 163: 1177-84.
8. Pfeffer K., Matsuyama T., Kündig T.M., Wakeham A., Kishihara K., Shahinian A., Wiegmann K., Ohashi P.D., Kronke M., Mak T.W. (1993) Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection. Cell 73: 457-67.
9. Espat N.J., Auffenberg T., Abouhamze A., Baumhofer J., Moldawer L.L., Howard R.J. (1996) A role for tumor necrosis factor-α in the increased mortality associated with Vibrio vulnificus infection in the presence of hepatic dysfunction. Ann Surg 223: 428-33.
10. Powell J.L., Wright A.C., Wasserman S.S., Hone D.M., Morris J.G. Jr. (1997) Release of tumor necrosis factor-α in response to Vibrio vulnificus capsular polysaccharide in in vivo and in vitro models. Infect Immun 65: 3713-18.
11. Brun-Buisson C.J., Saada M., Trunet P., Rapin M., Roujeau J.C., Revuz J. (1985) Haemolytic streptococcal gangrene and non-steroidal anti-inflammatory drugs. Br Med J (Clin Res Ed) 290: 1786.
12. Brandts C.H., Ndjave M., Graninger W., Kremsner P.G. (1997) Effect of paracetamol on parasite clearance time in Plasmodium falciparum malaria. Lancet 350: 704-9.
13. Solomon L. (1966) Activation of latent infection by indomethacin: a report of three cases. BMJ 1: 961-2.
14. Aronoff D.M., Bloch K.C. (2003) Assessing the relationship between the use of nonsteroidal anti-inflammatory drugs and necrotizing fasciitis caused by group A streptococcus. Medicine (Baltimore) 82: 225-35.
15. Chiang S.R., Tang H.J., Chang P.C., Cheng K.C., Ko W.C., Chen C.H., Chuang YC. (2007) Synergistic antimicrobial effect of cefotaximine and minocycline on proinflammatory cytokine levels in a murine model of Vibrio vulnificus infection. J Microbiol Immunol Infect 40: 123-33.
16. Blake P.A., Merson M.H., Weaver R.E., Hollis D.G., Heublein P.C. (1979) Disease caused by marine Vibrio: clinical characteristics and epidemiology. N Engl J Med 300: 1-5.
17. Morris J.G. Jr, Black R.E. (1985) Cholera and other vibrioses in the United States. N Engl J Med 312: 343-350.
18. Chuang Y.C., Ko W.C., Wang S.T., Liu J.W., Kuo C.F., Wu J.J., Huang K.Y. (1998) Minocycline and cefotaxime in the treatment of experimental murine Vibrio vulnificus infection. Antimicrob Agents Chemother 42: 1319-22.
19. Shin S.H., Shin D.H., Ryu P.Y., Chung S.S., Rhee J.H. (2002) Proinfammatory cytokine profile in Vibrio vulnifcus septicemic patients' sera. FEMS Immunol Med Microbiol 33: 133-138.
20. Pettipher E.R., Wimberly D.J. (1994) Cyclooxygenase inhibitors enhance tumour necrosis factor production and mortality in murine endotoxic shock. Cytokine 6: 500-3.
21. Endres S., Whitaker R.E., Ghorbani R., Meydani S.N., Dinarello C.A. (1996) Oral aspirin and ibuprofen increase cytokine-induced synthesis of IL-1 beta and of tumour necrosis factor-α ex vivo. Immunology 87: 264-70.
22. Sipe J.D., Bartle L.M., Loose L.D. (1992) Modification of proinflammatory cytokine production by the antirheumatic agents tenidap and naproxen. A possible correlate with clinical acute phase response. J Immunol 148: 480-4.
23. Marcouiller P., Pelletier J.P., Guévremont M., Martel-Pelletier J., Ranger P., Laufer S., Reboul P. (2005) Leukotriene and prostaglandin synthesis pathways in osteoarthritic synovial membranes: regulating factors for interleukin 1beta synthesis. J Rheumatol 32: 704-12.
24. Bernard G.R., Wheeler A.P., Russell J.A., Schein R., Summer W.R., Steinberg K.P., Fulkerson W.J., Wright P.E., Christman B.W., Dupont W.D., Higgins S.B., Swindell B.B. (1997) The effects of ibuprofen on the physiology and survival of patients with sepsis. The Ibuprofen in Sepsis Study Group. N Engl J Med 336: 912-18.
25. Stevens D.L. (1995) Could nonsteroidal anti-inflammatory drugs (NSAIDs) enhance the progression of bacterial infections to toxic shock syndrome? Clin Infect Dis 21: 977-80.
26. Souyri C., Olivier P., Grolleau S., Lapeyre-Mestre M. (2008) French Network of Pharmacovigilance Centres. Severe necrotizing soft-tissue infections and nonsteroidal anti-inflammatory drugs. Clin Exp Dermatol 33: 249-55.
27. Martich G.D., Danner R.L., Ceska M., Suffredini A.F. (1991) Detection of interleukin 8 and tumor necrosis factor in normal humans after intravenous endotoxin: the effect of anti-inflammatory agents. J Exp Med 173: 1021-24.
28. Tanaka K., Suemasu S., Ishihara T., Tasaka Y., Arai Y., Mizushima T. (2009) Inhibition of both COX-1 and COX-2 and resulting decrease in the level of prostaglandins E2 is responsible for non-steroidal anti-inflammatory drug (NSAID)-dependent exacerbation of colitis. Eur J Pharmacol 603: 120-32.
29. Ertel W., Morrison M.H., Ayala A., Perrin M.M., Chaudry I.H. (1991) Blockade of prostaglandin production increases cachectin synthesis and prevents depression of macrophage functions after hemorrhagic shock. Ann Surg 213: 265-71.
30. Ashorobi R.B., Williams P.A. (1995) Indomethacin and alpha-tocopheral enhanced survival in endotoxic rats. Cent Afr J Med 41: 216-19.
31. Mansilla-Roselló A., Ferrón-Orihuela J.A., Ruiz-Cabello F., Garrote-Lara D., Fernández-Mondéjar E., Delgado-Carrasco M.L. (1997) Differential effects of IL-1 beta and ibuprofen after endotoxic challenge in mice. J Surg Res 67: 199-204.
32. Tugendreich S., Pearson C.I., Sagartz J., Jarnagin K., Kolaja K. (2006) NSAID-induced acute phase response is due to increased intestinal permeability and characterized by early and consistent alterations in hepatic gene expression. Toxicol Pathol 34: 168-79.
33. Kyrkanides S., Moore A.H., Olschowka J.A., Daeschner J.C., Williams J.P., Hansen J.T., Kerry O'Banion M. (2002) Cyclooxygenase-2 modulates brain inflammation-related gene expression in central nervous system radiation injury. Brain Res Mol Brain Res 104: 159-69.